Capital Investment Advisors LLC Has $810,000 Holdings in Colgate-Palmolive Company $CL

Capital Investment Advisors LLC trimmed its position in shares of Colgate-Palmolive Company (NYSE:CL) by 3.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,911 shares of the company’s stock after selling 304 shares during the quarter. Capital Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $810,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of CL. Brighton Jones LLC raised its position in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the last quarter. NBC Securities Inc. raised its holdings in shares of Colgate-Palmolive by 112,160.0% in the first quarter. NBC Securities Inc. now owns 5,613 shares of the company’s stock valued at $525,000 after buying an additional 5,608 shares during the last quarter. Gradient Investments LLC lifted its position in Colgate-Palmolive by 9.7% during the 1st quarter. Gradient Investments LLC now owns 3,370 shares of the company’s stock worth $316,000 after buying an additional 299 shares in the last quarter. Merit Financial Group LLC grew its holdings in Colgate-Palmolive by 13.6% during the 1st quarter. Merit Financial Group LLC now owns 34,809 shares of the company’s stock worth $3,262,000 after acquiring an additional 4,169 shares during the last quarter. Finally, RFG Advisory LLC increased its position in Colgate-Palmolive by 85.6% in the 1st quarter. RFG Advisory LLC now owns 9,104 shares of the company’s stock valued at $853,000 after acquiring an additional 4,199 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 1.2%

Shares of NYSE CL opened at $78.95 on Thursday. Colgate-Palmolive Company has a 52-week low of $78.76 and a 52-week high of $102.61. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The stock has a market cap of $63.81 billion, a P/E ratio of 22.18, a P/E/G ratio of 4.16 and a beta of 0.34. The firm has a 50 day moving average price of $83.69 and a 200 day moving average price of $88.50.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period last year, the firm posted $0.91 earnings per share. The business’s quarterly revenue was up 1.0% compared to the same quarter last year. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.43%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. UBS Group reduced their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a research report on Thursday, July 17th. JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Citigroup cut their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research report on Monday, August 4th. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research report on Thursday, September 25th. Finally, Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Seven analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $97.27.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.